Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$79.4 - $116.36 $7.31 Million - $10.7 Million
-92,100 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$86.42 - $109.81 $7.96 Million - $10.1 Million
92,100 New
92,100 $9.69 Million
Q4 2021

Feb 10, 2022

SELL
$98.56 - $119.91 $2.12 Million - $2.58 Million
-21,500 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$91.91 - $110.37 $1.53 Million - $1.83 Million
16,600 Added 338.78%
21,500 $2.36 Million
Q1 2021

May 17, 2021

SELL
$71.83 - $95.48 $2.87 Million - $3.81 Million
-39,900 Reduced 89.06%
4,900 $451,000
Q2 2020

Aug 12, 2020

BUY
$30.2 - $56.98 $1.17 Million - $2.2 Million
38,600 Added 622.58%
44,800 $2.49 Million
Q1 2020

May 13, 2020

SELL
$24.87 - $38.56 $833,145 - $1.29 Million
-33,500 Reduced 84.38%
6,200 $184,000
Q4 2019

Feb 14, 2020

BUY
$25.43 - $36.67 $1.01 Million - $1.46 Million
39,700 New
39,700 $1.44 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.